
Talimus Ointment
Description
Talimus Ointment is used to treat eczema (atopic dermatitis). It works by suppressing the activity of certain immune cells that cause inflammation (redness and swelling) of the skin. This relieves itching and improves rashes in atopic dermatitis.
Product Information
Form
Ointment
Strength
0.1%
Pack Size
5 gm in 1 tube
Storage
Store below 25°C
Manufactured By
Ajanta Pharma Limited
Marketed By / TM Owner
Ajanta Pharma Limited
Institutional Quality & Supply Assurance
Meeting Global Pharmaceutical Standards for Trusted International Trade
Procured through authorised distributors and companies, ensuring reliable quality and supply chain traceability.
Active temperature logging during air cargo export, maintaining Refrigerated (2°C–8°C) and CRT (15°C–25°C) conditions as per international shipping standards.
Pre-dispatch inspection, tamper-evident packing, and documentation verification for every shipment.
Uses
Treatment of Atopic dermatitis
Disclaimer
At ExSell Laboratories Pvt. Ltd., we aim to provide information that is accurate and reliable. All content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While every effort is made to maintain accuracy, the information provided may contain errors or omissions, or may not reflect the latest developments. Please consult a qualified healthcare professional regarding any medical concerns.
All product names, brand names, trademarks, and registered trademarks displayed on this website are the property of their respective owners. ExSell Laboratories Pvt. Ltd. and this website are not affiliated with, endorsed by, or authorized by any such trademark owners, unless expressly stated. References to product names or trademarks are made solely for descriptive and informational purposes, and no commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Nothing herein constitutes promotion, advertising, or an offer for sale of any medicinal product.
All trademarks and brand names on this website are used strictly in accordance with the Trade Marks Act, 1999 — specifically Sections 30 and 30(1) governing fair use — and any related parallel trade is conducted consistent with the trademark exhaustion and fair-use provisions of the Act, as well as India's obligations as a WTO member under the TRIPS Agreement.
"Trademark ownership is duly attributed under the 'Marketing/TM Owner' section in accordance with applicable statutory requirements."
Frequently Asked Questions about Talimus Ointment
Essential information on active composition, quality standards, cold-chain storage, and international export.
What is Talimus Ointment and what active ingredient does it contain?
Talimus Ointment is a certified pharmaceutical product from our Global export catalogue formulated as an Ointment (0.1%). It contains the active pharmaceutical ingredient Tacrolimus (0.1%), manufactured by Ajanta Pharma Limited.
Who manufactures Talimus Ointment and is it quality certified?
Talimus Ointment is manufactured by Ajanta Pharma Limited – Meeting Global Pharmaceutical Standards for Trusted International Trade. ExSell Laboratories delivers authenticated batches sourced through verified, compliant supply channels, backed by complete regulatory documentation.
How should Talimus Ointment be stored to maintain potency?
Talimus Ointment must be stored according to manufacturer instructions: Store below 25°C. ExSell Laboratories maintains active temperature logging during air cargo export, maintaining Refrigerated (2°C–8°C) and CRT (15°C–25°C) conditions as per international shipping standards.
Can Talimus Ointment be ordered in bulk for international export?
Yes, ExSell Laboratories is a licensed global pharmaceutical exporter supplying hospitals, pharmacies, government procurement agencies, and distributors in 45+ countries. Contact our sales team for bulk quotation, MOQ, and international shipping options.
Substitutes & Brands with Tacrolimus (0.1%)
Verified equivalent brands and bioequivalent formulations containing Tacrolimus (0.1%).



